Takashi Morimoto
Yao municipal hospital, Japan

Title: The Effect Of T-DM1 In the Late Line for Advanced or Recurrent HER2 Positive Breast Cancer Patients

Biography :

TBD....... Read more

Christian M. Kurbacher
Gynecological Center, Germany

Title: CDK4/6 inhibition plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: results of randomized clinical trials and clinical reality in Europe

Biography :

TBD....... Read more

Ming-Shen Dai
National Defense Medical Center, Taiwan

Title: Risk Analysis of Recurrence from Pathological Complete Remission (Pcr) after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients

Biography :

TBD....... Read more

Ahmed M. Malki
Qatar University, Qatar

Title: Novel Iosteviol Analogs Induced Apoptosis in Breast Cancers

Biography :

Dr Malki is an associate professor of Biomedical Science and Associate Dean of College of Health Sciences at Qatar University. Dr Ahmed M Malki received his PhD in Biochemistry in 2006 in the field of Molecular Oncology from Edison Institute of Biotechnology, ....... Biochemistry Department, Ohio University in USA and held postdoctoral position at University of California Berkeley, USA via NIH grant in 2007. Dr Malki also received Best Research Award from global Breast Cancer conference, 2011, Seoul, South Korea and Alexandria University Award for Scientific encouragement in 2012. Dr Malki has received best poster award at Annual research Day 2014 and QU research forum 2015, 2018. Dr Malki is a member of QU Health Cluster Committee, Led thematic research and graduate studies group for establishment of QU health cluster, led team to launch joint PhD Program for QU health cluster, member of thematic academic group for establishment of QU health cluster and member of QU health cluster advisory board. Dr Malki awarded international and national grants for discovery of novel small molecules targeting cancer cells; he has many peer reviewed international publications and He is serving in editorial board member in number of international journals. Dr Malki presented his research as invited speaker at international conferences and professional meetings. The central theme of Dr Malki's research is the understanding of the signaling pathways that regulate cell proliferation, cell death and designing novel anticancer drugs targeting p53 Read more

Tarek Mohamed Kamal M Metawie
Cairo University, Egypt

Title: Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt

Biography :

Dr Tarek Mohamed Kamal Mohamed Metawie, Professor of Biochemistry, Faculty of Pharmacy, Cairo University. Egyptian, Ph.D. in Pharmaceutical Sciences, 1984; M.Sc. in Pharmaceutical Sciences, 1979; B.Sc. in Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University, 1976.,....... Professional experience: Instructor; 1976, Lecturer Assistant; 1980, Lecturer, 1984; Assistant Professor, 1989; Professor,1994; Head of the Department of Biochemistry, Faculty of Pharmacy, Cairo:- 2008-2014. Read more